Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Episode 5 July 07, 2021 00:51:14
Episode 5:  Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Jul 07 2021 | 00:51:14

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

Other Episodes

Episode 38

May 23, 2024 00:35:24
Episode Cover

Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health

"It's amazing how many companies there are and how many opportunities for a kind of a match between a human that needs some help...

Listen

Episode 10

September 15, 2021 00:44:02
Episode Cover

Episode 10: Sharon Terry, CEO Genetic Alliance

Why is the sharing of data so crucial to #raredisease research? Tune in for today's full episode of Few & Far Between. Episode 10...

Listen

Episode 30

May 03, 2023 00:45:07
Episode Cover

Episode 30, Part One: Dr. Francisco Harrison, CEO and owner, Harrison CST Holding GmbH

"I love clinical research. I will spend my life in clinical research." Dr. Francisco Harrison, CEO and owner, Harrison CST Holding GmbH Biorasi welcomes...

Listen